A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer

Published:2018 Issue:6 Volume:94 Page:373-382
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Park Cheol-Kyu,Oh In-Jae^ORCID,Choi Yoo-Duk,Jang Tae-Won,Lee Jeong-Eun,Ryu Jeong-Seon,Lee Shin-Yup,Kim Young-Chul

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference33 articles.

1. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915–925.

2. Masuya D, Huang C, Liu D, Nakashima T, Kameyama K, Haba R, Ueno M, Yokomise H: The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients. Br J Cancer 2004; 90: 1555–1562.

3. Huang L, An SJ, Chen ZH, Su J, Yan HH, Wu YL: MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation. J Thorac Oncol 2014; 9: 725–728.

4. Chang H, Zhang X, Cho BC, Park HJ, Kim JH: Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors. Thorac Cancer 2014; 5: 517–524.

5. Park S, Choi YL, Sung CO, An J, Seo J, Ahn MJ, Ahn JS, Park K, Shin YK, Erkin OC, Song K, Kim J, Shim YM, Han J: High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histol Histopathol 2012; 27: 197–207.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review;Molecular Diagnosis & Therapy;2022-03

2. EGFR mutation is positively correlated with C-Met protein expression: a study of 446 resected lung adenocarcinoma;Translational Cancer Research;2021-01

3. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers;Critical Reviews in Clinical Laboratory Sciences;2019-09-12

4. Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerability;PLOS ONE;2019-04-11